2 recruiting, 2 unknown, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow JAK2 Mutation: new trials by email Literature Review of JAK2 Mutation trials Research Report on JAK2 Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ropeg-Interferon in People With Polycythemia Vera Ropeginterferon - Polycythemia Vera (PV), JAK2 Mutation | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 55 | 2026-10-30 | 2026-11-03 |
| Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis Ropeginterferon - JAK2 Mutation | Phase 1 | Recruiting | Brigham and Women's Hospital | 12 | 2026-07-24 | 2026-07-28 |
| Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome Rotational thromboelastometry, Genetic tests for Thrombophilia, ELISA tests/ Functional assays - Hepatic Vein Thromboses, Hepatic Venous Outflow Obstruction | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 300 | 2021-10-15 | 2024-02-13 | |
| Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients Apixaban 2.5 MG Oral Tablet [ELIQUIS], Aspirin 81 mg - Myeloproliferative Neoplasm (MPN), Essential Thrombocythemia (ET) | Phase 2 | Completed | Ottawa Hospital Research Institute | 44 | 2021-02-17 | 2024-05-29 |
| Anticoagulation in Gastroesophageal Varices and JAK2 Mutation Anticoagulation Agents - Gastroesophageal Varices, JAK2 Mutation | Unknown | Shanghai Zhongshan Hospital | 40 | 2020-10-01 | 2020-08-27 |
Myeloproliferative Disorders (3) · Hypertension, Portal (2) · Polycythemia Vera (2) · Budd-Chiari Syndrome (1) · Hemostatic Disorders (1) · Primary Myelofibrosis (1) · Thrombocythemia, Essential (1) · Venous Thromboembolism (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Bone Marrow Diseases (4) · Bone Marrow Neoplasms (2) · Cardiovascular Diseases (2) · Digestive System Diseases (2) · Embolism and Thrombosis (2) · Hematologic Neoplasms (2) · Hemorrhagic Disorders (2) · Liver Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Vascular Diseases (2) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1)
Anticoagulants (1) · Aspirin (1) · Genetic Testing (1) · Tablets (1) · apixaban (1)
Brigham and Women's Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · Ottawa Hospital Research Institute (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Shanghai Zhongshan Hospital (1)
United States (2) · Canada (1) · India (1)
Aurelien Delluc, MD, PhD (1) · Chi-Joan How (1) · Madhumita Premkumar, MD DM (1) · Miriam Kimpton, MD (1) · Raajit Rampal, MD, PhD (1)